Ganirelix Acetate

醋酸加尼瑞克

Report date: 2022/05/16 08:59:28
NME

Base Information

Drug NameGanirelix Acetate
Drug Alias Name加尼瑞克ganirelixganirelixumOrgalutranAntagon +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGonadotropin-releasing hormone receptor antagonists
TargetsGonadotropin-releasing hormone receptor
Therapy Area/IndicationsEndocrine System DiseasesInfertility, FemaleEndometriosis
Global Approved IndicationsEndocrine System DiseasesInfertility, Female
Approved Indications in ChinaInfertility, Female
Original Approved Country/TerritoryUnited States
Original Approved Date1999/07/29
Country/TerritoryUnited StatesEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesOrganon
China Registration ClassN/A

Develop Information

Active CompaniesYale UniversityOrganon Usa IncN.V. Organon +[4] 
Inactive CompaniesN/A
Active IndicationsEndocrine System DiseasesInfertility, FemaleEndometriosis
Inactive IndicationsN/A

Other Information

ATC CodeH01CC01
Related LinksWikipediaDrugBankKEGG